Results 221 to 230 of about 81,593 (273)
Sphingomyelin and Cholesterol Promote HIV-1 gp41 Pretransmembrane Sequence Surface Aggregation and Membrane Restructuring [PDF]
Asier Sáez‐Cirión +6 more
openalex +1 more source
We performed UPLC‐MS/MS lipidomics and DIA proteomics on plasma from healthy controls, active TB patients, and cured patients, and used Mendelian randomization to prioritize diagnostic and cure biomarkers. Multi‐omics random‐forest models based on these biomarkers showed excellent performance for diagnosis and cure monitoring.
Chenglin Zhu +9 more
wiley +1 more source
CCR2 orchestrates preferential homing of GMSC‐derived extracellularvesicles to inflamed joints in rheumatoid arthritis. ABSTRACT The clinical utility of mesenchymal stem cells (MSCs) is often limited by pulmonary entrapment and poor systemic distribution, particularly in diseases constrained by physiological barriers such as rheumatoid arthritis (RA ...
Jingrong Chen +13 more
wiley +1 more source
Potential endogenous lipid ligands for the nuclear receptor transcription factor Steroidogenic Factor-1. [PDF]
Campbell AN, Blind RD.
europepmc +1 more source
Clinical and Translational Medicine, Volume 16, Issue 1, January 2026.
Laura E. Kane +21 more
wiley +1 more source
Modulators of Diacylglycerol Kinase Activity: A Review of Advances and Challenges
ABSTRACT Catalyzing the conversion of diacylglycerol (DAG) in phosphatidic acid (PA), diacylglycerol kinases (DGKs) play a pivotal role in all the physiological processes modulated by these two bioactive lipids, such as lipid metabolism and immune regulation.
Luisa Racca +2 more
wiley +1 more source
Exploring Causal Associations Between Plasma Metabolites and Autism Spectrum Disorder. [PDF]
Shi S, Baranova A, Cao H, Zhang F.
europepmc +1 more source
Computational modelling of lipid bilayers with sphingomyelin and sterols
Perttu Niemelä
openalex +1 more source
Dysbiosis‐induced alterations in microbial metabolite production promote intestinal barrier disruption and systemic inflammation, driving insulin resistance and metabolic dysfunction. Microbiota‐targeting therapies represent promising approaches to restore host metabolic health.
Mohamad Al Qassab +10 more
wiley +1 more source

